Dr Reddy’s Mexico API facility gets two observations from USFDA
· thehindubusinessline.com
Dr Reddy’s Laboratories said the USFDA completed a records assessment of its Mexico API facility and issued two observations in Form FDA 2953.
Pharmaceutical major Dr Reddy's Laboratories on Friday said the US health regulator has conducted a records assessment of its active pharmaceutical ingredient (...